KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Amortization - Intangibles (2016 - 2025)

Globus Medical's Amortization - Intangibles history spans 11 years, with the latest figure at $29.4 million for Q4 2025.

  • For Q4 2025, Amortization - Intangibles fell 1.85% year-over-year to $29.4 million; the TTM value through Dec 2025 reached $89.4 million, down 25.07%, while the annual FY2025 figure was $118.2 million, 0.99% down from the prior year.
  • Amortization - Intangibles reached $29.4 million in Q4 2025 per GMED's latest filing, down from $29.8 million in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $30.2 million in Q2 2025 to a low of $49000.0 in Q1 2025.
  • Average Amortization - Intangibles over 5 years is $14.8 million, with a median of $4.7 million recorded in 2021.
  • Peak YoY movement for Amortization - Intangibles: soared 553.38% in 2024, then crashed 99.83% in 2025.
  • A 5-year view of Amortization - Intangibles shows it stood at $4.6 million in 2021, then fell by 1.1% to $4.5 million in 2022, then skyrocketed by 524.12% to $28.1 million in 2023, then increased by 6.36% to $29.9 million in 2024, then dropped by 1.85% to $29.4 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Amortization - Intangibles are $29.4 million (Q4 2025), $29.8 million (Q3 2025), and $30.2 million (Q2 2025).